We might have to wait a little longer for a resolution in the Brock Lesnar doping case.
Lesnar's legal team has requested a continuance for his Nevada Athletic Commission (NAC) disciplinary hearing, per a document obtained by MMA Fighting through a public records request. ESPN's Brett Okamoto was the first to report it.
The former UFC heavyweight champion would have had his doping case heard before the NAC on Nov. 10, but if the continuance is granted the hearing won't be until December at the earliest. Typically, these requests are granted.
Lesnar's attorney Howard Jacobs made the request, because Lesnar is having a foot cream he took tested to see if comes back for the banned substance he tested positive for, clomiphene, the lawyer wrote in the request. Jacobs said Lesnar is having the foot cream tested with the help of USADA, the UFC's anti-doping partner, at the WADA-accredited lab in Salt Lake City. That testing will not be completed until after the proposed Nov. 10 hearing date, Jacobs wrote.
Jacobs wrote that Lesnar also had an eye medication tested independently in an effort to find out what caused his positive test, but the eye medication came back negative for clomiphene.
Lesnar is also facing sanctions from USADA for failing two drug tests in relation to UFC 200 for clomiphene, which is an anti-estrogen agent. His adjudication process with USADA is ongoing. Lesnar tested positive for the drug in both in-competition and out-of-competition tests, the latter coming before the fight. USADA was not able to get the results back before UFC 200. Lesnar beat Mark Hunt on the card by unanimous decision.
That result could be overturned by the commission to a no contest. The NAC could also fine and suspend Lesnar, while USADA will likely only suspend him. The two suspension lengths don't have to be the same. Lesnar is facing a maximum of a one-year suspension from USADA. There's no official cap for NAC suspensions.
Though Lesnar might not be on the docket, the NAC will hold its disciplinary hearing with Jon Jones on Nov. 10. Jones tested positive for clomiphene and Letrozol, both anti-estrogren agents, in an out-of-competition test before UFC 200 and was pulled from the card three days prior to what would have been a title fight with Daniel Cormier.
Jones had his USADA arbitration Monday in Los Angeles and the decision is expected back before the NAC hearing next week after an expedite was requested by Jones' team. Jones and Lesnar have the same lawyer, Jacobs, a leading anti-doping attorney.
Also on the NAC agenda for Nov. 10 will likely be the disciplinary hearing for Nate Diaz, who was involved in an water bottle-throwing incident with his team, Conor McGregor and McGregor's team at a press conference before UFC 202 in August.